Literature DB >> 20236762

Assessment and classification of cancer breakthrough pain: a systematic literature review.

Dagny Faksvåg Haugen1, Marianne Jensen Hjermstad, Neil Hagen, Augusto Caraceni, Stein Kaasa.   

Abstract

Temporal variations in cancer pain intensity are highly prevalent, and are often difficult to manage. However, the phenomenon is not well understood: several definitions and approaches to classification and bedside assessment of cancer breakthrough pain (BTP) have been described. The present study is a systematic review of published literature on cancer BTP to answer the following questions: which terms and definitions have been used; are there validated assessment tools; which domains of BTP do the tools delineate, and which items do they contain; how have assessment tools been applied within clinical studies; and are there validated classification systems for BTP. A systematic search of the peer-reviewed literature was performed using five major databases. Of 375 titles and abstracts initially identified, 51 articles were examined in detail. Analysis of these publications indicates a range of overlapping but distinct definitions have been used to characterize BTP; 42 of the included papers presented one or more ways of classifying BTP; and while 10 tools to assess patients' experience of BTP were identified, only 2 have been partially validated. We conclude that there is no widely accepted definition, classification system or well-validated assessment tool for cancer-related breakthrough pain, but there is strong concurrence on most of its key attributes. With further work in this area, an internationally agreed upon definition and classification system for cancer-related breakthrough pain, and a standard approach on how to measure it, hold the promise to improve patient care and support research in this poor-prognosis cancer pain syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20236762     DOI: 10.1016/j.pain.2010.02.035

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  40 in total

1.  Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).

Authors:  J Porta-Sales; C Pérez; Y Escobar; V Martínez
Journal:  Clin Transl Oncol       Date:  2015-12-22       Impact factor: 3.405

2.  Understanding the Chameleonic Breakthrough Cancer Pain.

Authors:  Sebastiano Mercadante; Russell K Portenoy
Journal:  Drugs       Date:  2021-01-30       Impact factor: 9.546

3.  A philosophical critique of the UK's National Institute for Health and Care Excellence guideline 'Palliative care for adults: strong opioids for pain relief'.

Authors:  David Fearon; Sean Hughes; Sarah G Brearley
Journal:  Br J Pain       Date:  2018-01-10

4.  Abstral (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain).

Authors: 
Journal:  P T       Date:  2011-02

5.  Comparative responsiveness of pain measures in cancer patients.

Authors:  Kurt Kroenke; Dale Theobald; Jingwei Wu; Wanzhu Tu; Erin E Krebs
Journal:  J Pain       Date:  2012-07-15       Impact factor: 5.820

Review 6.  Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group.

Authors:  Sebastiano Mercadante; Paolo Marchetti; Arturo Cuomo; Massimo Mammucari; Augusto Caraceni
Journal:  Support Care Cancer       Date:  2015-10-05       Impact factor: 3.603

7.  Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study.

Authors:  R López López; C Camps Herrero; P Khosravi-Shahi; V Guillem Porta; A Carrato Mena; J Garcia-Foncillas; J J Cruz Hernández; P Gascón Vilaplana; A Antón Torres; E Diaz-Rubio; M Feyjoo Saus; E Aranda Aguilar
Journal:  Clin Transl Oncol       Date:  2017-10-03       Impact factor: 3.405

8.  Is it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart.

Authors:  Morten Thronæs; Sunil X Raj; Cinzia Brunelli; Sigrun Saur Almberg; Ola Magne Vagnildhaug; Susanna Bruheim; Birgit Helgheim; Stein Kaasa; Anne Kari Knudsen
Journal:  Support Care Cancer       Date:  2015-12-28       Impact factor: 3.603

9.  Safety profile of intravenous patient-controlled analgesia for breakthrough pain in cancer patients: a case series study.

Authors:  Angela Maria Sousa; José de Santana Neto; Gabriel M N Guimaraes; Giovana M Cascudo; José Osvaldo B Neto; Hazem A Ashmawi
Journal:  Support Care Cancer       Date:  2013-11-21       Impact factor: 3.603

10.  Mediation of Movement-Induced Breakthrough Cancer Pain by IB4-Binding Nociceptors in Rats.

Authors:  Joshua Havelin; Ian Imbert; Devki Sukhtankar; Bethany Remeniuk; Ian Pelletier; Jonathan Gentry; Alec Okun; Timothy Tiutan; Frank Porreca; Tamara E King
Journal:  J Neurosci       Date:  2017-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.